Delivery Order SPE2DB24D3013-SPE2DB25FFQTQ
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Enoxaparin 100 mg/ml syringes valued at $2,467.17. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,518.74 delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Enoxaparin 40 mg/0.4 mL syringes with an ultimate completion date of September 2, 2025. This competitive award, priced on a firm fixed-price basis with no set-aside designation, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Enoxaparin 300 mg/3 ml vials with a ceiling value of $1,372.20. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The contract was awarded on a competitive basis with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a $1,135.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 150 mg/mL enoxaparin syringes, with a period of performance through May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,916.80 on July 31, 2025, for the supply of Enoxaparin 300 mg/3 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 1, 2025, and performance will be executed from the awardee's facility in Conshohocken, Pennsylvania. Enoxaparin is a low-molecular-weight heparin used for anticoagulation therapy in military and federal healthcare settings. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,351.76 firm fixed-price delivery order is for the supply of 4567089316 units of 150 mg/mL enoxaparin syringes. The award has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $2,841.38 firm fixed price contract is for the supply of 100 mg/mL Enoxaparin syringes. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Enoxaparin 150 mg/mL syringes. The $1,303.68 contract has a performance period through March 21, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp provides a wide range of pharmaceutical and medical supply products to support military treatment programs and facilities under multiple DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,478.35 firm fixed-price contract is for the delivery of 80 mg/0.8 mL syringes of the anticoagulant drug enoxaparin, with a completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Enoxaparin 40 mg/0.4 ml syringes. The firm-fixed-price, delivery order contract has a ceiling value of $3,396.94 and a performance period ending on September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables...